Cargando…
The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
SIMPLE SUMMARY: Fibrosis is a common response to chronic tissue injury and plays a critical role in many diseases across medical subspecialties. To date, there are few therapies with limited effectiveness to treat fibrotic diseases. Expression of mesothelin was detected in activated Portal Fibroblas...
Autores principales: | Nishio, Takahiro, Koyama, Yukinori, Fuji, Hiroaki, Ishizuka, Kei, Iwaisako, Keiko, Taura, Kojiro, Hatano, Etsuro, Brenner, David A., Kisseleva, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687690/ https://www.ncbi.nlm.nih.gov/pubmed/36358290 http://dx.doi.org/10.3390/biology11111589 |
Ejemplares similares
-
The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021) -
Current status of preoperative risk assessment for posthepatectomy liver failure in patients with hepatocellular carcinoma
por: Nishio, Takahiro, et al.
Publicado: (2023) -
Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis
por: Taura, Kojiro, et al.
Publicado: (2016) -
Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies
por: Iwaisako, Keiko, et al.
Publicado: (2014) -
Acute coronary syndrome after liver transplantation in a young primary biliary cholangitis recipient with dyslipidemia: a case report
por: Yao, Siyuan, et al.
Publicado: (2022)